The Sarcoglycan Complex in Skeletal Muscle Mechanotransduction
骨骼肌机械转导中的肌聚糖复合物
基本信息
- 批准号:9247122
- 负责人:
- 金额:$ 39.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAffectBindingBiochemicalCancer EtiologyCell NucleusCellsCellular MechanotransductionClinical TrialsComplexDefectDiseaseDissectionDown-RegulationDrug usageDuchenne muscular dystrophyDystrophinEventFocal AdhesionsFutureGTP-Binding Protein alpha Subunits, GsGenesHealthHumanLeadLimb-Girdle Muscular DystrophiesMAPK3 geneMechanicsMediatingMembraneModelingMolecularMusMuscleMuscle ContractionMuscle FibersMuscle functionMuscle strainMuscular AtrophyMuscular DystrophiesMyopathyMyosin Type IINatureNeuromuscular DiseasesNuclearPathologicPathologyPathway interactionsPatientsPhosphorylationPhysical activityPositioning AttributePredispositionPropertyProtein IsoformsProtein SplicingProteinsResearchRestRoleSarcoglycansSarcolemmaSignal PathwaySignal TransductionSkeletal MuscleStimulusStretchingTherapeuticWorkbasefilamingamma Sarcoglycanimprovedknock-downmdx mousemechanical loadmechanotransductionmuscle degenerationmutantnon-muscle myosinnormal agingnovelnovel strategiesnovel therapeuticsprotein expressionpublic health relevanceresponsesensorsmall hairpin RNAtherapeutic development
项目摘要
DESCRIPTION (provided by applicant): Physical activity imposes changes in load to skeletal muscle, which adapts through acute changes in biochemical signaling pathways and longer-term alterations in protein expression. One important mechanical sensor is the sarcoglycan (SG) complex, which is lost from the muscle membrane (sarcolemma) in both Duchenne and Limb Girdle muscular dystrophies (LGMD). Absence of γ-SG loss induces severe muscle degeneration and signaling defects in response to mechanical load without causing susceptibility to contractile damage, suggesting that LGMD pathology arises in part through disruption of normal mechanotransduction signaling through the SG complex. In a recent advance, the applicants have discovered that archvillin, a muscle-specific isoform of supervillin, is a γ-SG- and dystrophin-interacting protein and that archvillin association with phosphorylated ERK1/2 (P-ERK) increases dramatically, if and only if γ-SG is present, following eccentric contraction of muscle. Aim 1 is to determine the molecular bases for the associations of archvillin with γ-SG and P-ERK at rest and following stretch. Aim 2 is to determine the consequences of archvillin loss upon mechanical signal transduction in normal and dystrophic muscles. Aim 3 is to use drugs in clinical trials for other diseases to determine how up- or down-regulation of the molecular pathways identified in preliminary studies and in Aim 1 affects the progression of muscle pathology in gsg-/- mice, a model for human LGMD2C. Completion of these aims will elucidate the role of archvillin in mechanochemical signal transduction in muscle, identify new proteins in SG-mediated signaling, and determine whether modulation of the identified pathways has therapeutic potential.
描述(申请人提供):体力活动对骨骼肌施加负荷的变化,骨骼肌通过生化信号通路的急剧变化和蛋白质表达的长期变化来适应。一个重要的机械感受器是肌聚糖(SG)复合体,在Duchenne和Limb Girdle肌营养不良症(LGMD)中,它从肌膜(肌膜)中消失。γ-SG缺失可导致严重的肌肉变性和信号缺陷,以响应机械负荷,而不会导致收缩损伤易感性,提示LGMD病理部分是通过破坏通过SG复合体的正常机械转导信号而发生的。在最近的进展中,申请人发现,超级绒毛蛋白的一种肌肉特异性亚型,是一种与γ-SG和dystrophin相互作用的蛋白质,并且当且仅当γ-SG存在时,随着肌肉的偏心收缩,与磷酸化ERK1/2(P-ERK1/2)相关的蛋白显著增加。目的1是确定γ-SG和P-ERK在静息和牵张后结合的分子基础。目的2是确定拱毛蛋白缺失对正常和营养不良肌肉的机械信号转导的影响。目标3是将药物用于其他疾病的临床试验,以确定在初步研究和目标1中确定的分子通路的上调或下调如何影响GSG-/-小鼠肌肉病理的进展,GSG-/-小鼠是人类LGMD2C的模型。这些目标的完成将阐明ARCHVILIN在肌肉机械力化学信号转导中的作用,识别SG介导的信号转导中的新蛋白质,并确定对已识别的信号通路的调制是否具有治疗潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elisabeth R Barton其他文献
Comments on Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. Is any factor necessary and sufficient for muscle mass regulation?
观点评论:对立点:IGF 是/不是肌肉质量的主要生理调节剂。
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:3.3
- 作者:
Elisabeth R Barton;A. Philippou - 通讯作者:
A. Philippou
Elisabeth R Barton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elisabeth R Barton', 18)}}的其他基金
The Chloroplast Expression System as a platform for orally bioavailable muscle therapeutics
叶绿体表达系统作为口服生物可利用肌肉治疗的平台
- 批准号:
9904474 - 财政年份:2019
- 资助金额:
$ 39.04万 - 项目类别:
The Sarcoglycan Complex in Skeletal Muscle Mechanotransduction
骨骼肌机械转导中的肌聚糖复合物
- 批准号:
9903225 - 财政年份:2016
- 资助金额:
$ 39.04万 - 项目类别:
Modulation of muscle regeneration by growth factors
生长因子调节肌肉再生
- 批准号:
8122854 - 财政年份:2011
- 资助金额:
$ 39.04万 - 项目类别:
Modulation of Muscle Regenerationby Growth Factors
生长因子对肌肉再生的调节
- 批准号:
8468119 - 财政年份:2010
- 资助金额:
$ 39.04万 - 项目类别:
Modulation of Muscle Regenerationby Growth Factors
生长因子对肌肉再生的调节
- 批准号:
8259528 - 财政年份:2010
- 资助金额:
$ 39.04万 - 项目类别:
Modulation of Muscle Regenerationby Growth Factors
生长因子对肌肉再生的调节
- 批准号:
8097454 - 财政年份:2010
- 资助金额:
$ 39.04万 - 项目类别:
Modulation of Muscle Regenerationby Growth Factors
生长因子对肌肉再生的调节
- 批准号:
8660649 - 财政年份:2010
- 资助金额:
$ 39.04万 - 项目类别:
Modulation of Muscle Regenerationby Growth Factors
生长因子对肌肉再生的调节
- 批准号:
7983586 - 财政年份:2010
- 资助金额:
$ 39.04万 - 项目类别:
IGF-I isoforms: a source for new agents to counter muscular dystrophy pathology
IGF-I 亚型:对抗肌营养不良症病理学的新药物来源
- 批准号:
7575778 - 财政年份:2008
- 资助金额:
$ 39.04万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 39.04万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 39.04万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 39.04万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 39.04万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 39.04万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 39.04万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 39.04万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 39.04万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 39.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 39.04万 - 项目类别:
Operating Grants














{{item.name}}会员




